Product References
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
EMBO molecular medicine
Güner G,Aßfalg M,Zhao K,Dreyer T,Lahiri S,Lo Y,Slivinschi BI,Imhof A,Jocher G,Strohm L,Behrends C,Langosch D,Bronger H,Nimsky C,Bartsch JW,Riddell SR,Steiner H,Lichtenthaler SF
14-9018-82 was used in Flow Cytometry to demonstrate a novel function for γ-secretase in attenuating TWEAK/Fn14 signaling and suggests the use of sFn14 as an easily measurable pharmacodynamic biomarker to monitor γ-secretase activity in vivo.
Mon Oct 10 00:00:00 UTC 2022
Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.
Biomaterials
Schneider CS,Perez JG,Cheng E,Zhang C,Mastorakos P,Hanes J,Winkles JA,Woodworth GF,Kim AJ
14-9018 was used in Flow cytometry/Cell sorting to explore the tumor-specific targeting capabilities of nanoparticles through a balance of minimized non-specific binding and highly specific binding to invasive brain tumor cells.
Sun Feb 01 00:00:00 UTC 2015
Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity.
Molecular endocrinology (Baltimore, Md.)
Cheng Q,Inaba Y,Lu P,Xu M,He J,Zhao Y,Guo GL,Kuruba R,de la Vega R,Evans RW,Li S,Xie W
Published figure using CD266 (TWEAK Receptor) monoclonal antibody (Product # 14-9018-82) in Western Blot
Wed Apr 01 00:00:00 UTC 2015
Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
The Journal of biological chemistry
Gurunathan S,Winkles JA,Ghosh S,Hayden MS
14-9018 was used in Flow cytometry/Cell sorting to examine Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis.
Fri May 09 00:00:00 UTC 2014
Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
The Journal of biological chemistry
Gurunathan S,Winkles JA,Ghosh S,Hayden MS
14-9018 was used in Flow cytometry/Cell sorting to examine Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis.
Fri May 09 00:00:00 UTC 2014
HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Arteriosclerosis, thrombosis, and vascular biology
Moreno JA,Sastre C,Madrigal-Matute J,Muñoz-García B,Ortega L,Burkly LC,Egido J,Martín-Ventura JL,Blanco-Colio LM
14-9018 was used in Flow cytometry/Cell sorting to indicate that TWEAK can regulate expression and secretion of HMGB1 in monocytes/macrophages, associated with atherosclerotic plaque development.
Fri Mar 01 00:00:00 UTC 2013
Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.
Experimental and therapeutic medicine
Yoriki R,Akashi S,Sho M,Nomi T,Yamato I,Hotta K,Takayama T,Matsumoto S,Wakatsuki K,Migita K,Yagita H,Nakajima Y
14-9018 was used in Immunohistochemistry to investigate the potential of TWEAK and Fn14 in oesophageal and pancreatic cancer, as novel molecular targets for anti-cancer therapy.
Sat Jan 01 00:00:00 UTC 2011
Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.
Journal of immunology (Baltimore, Md. : 1950)
Roos C,Wicovsky A,Müller N,Salzmann S,Rosenthal T,Kalthoff H,Trauzold A,Seher A,Henkler F,Kneitz C,Wajant H
Sun Aug 01 00:00:00 UTC 2010
The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
Atherosclerosis
Moreno JA,Muñoz-García B,Martín-Ventura JL,Madrigal-Matute J,Orbe J,Páramo JA,Ortega L,Egido J,Blanco-Colio LM
Sun Nov 01 00:00:00 UTC 2009
TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Journal of leukocyte biology
Desplat-Jégo S,Feuillet L,Creidy R,Malikova I,Rance R,Khrestchatisky M,Hahm K,Burkly LC,Pelletier J,Boucraut J
14-9018 was used in Flow cytometry/Cell sorting to demonstrate that TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Thu Jan 01 00:00:00 UTC 2009
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia.
Journal of cellular and molecular medicine
Sanz AB,Sanchez-Niño MD,Izquierdo MC,Jakubowski A,Justo P,Blanco-Colio LM,Ruiz-Ortega M,Egido J,Ortiz A
14-9018 was used in Neutralization experiments to show that TWEAK increased the proliferation, cell number and cyclin D1 expression of cultured tubular cells, in vitro.
Tue Sep 01 00:00:00 UTC 2009
The cytokine TWEAK modulates renal tubulointerstitial inflammation.
Journal of the American Society of Nephrology : JASN
Sanz AB,Justo P,Sanchez-Niño MD,Blanco-Colio LM,Winkles JA,Kreztler M,Jakubowski A,Blanco J,Egido J,Ruiz-Ortega M,Ortiz A
14-9018 was used in Western Blotting to demonstrate that TWEAK has NF-kappaB-dependent proinflammatory effects on tubular epithelial cells in vitro and in vivo.
Tue Apr 01 00:00:00 UTC 2008
TWEAK induces liver progenitor cell proliferation.
The Journal of clinical investigation
Jakubowski A,Ambrose C,Parr M,Lincecum JM,Wang MZ,Zheng TS,Browning B,Michaelson JS,Baetscher M,Wang B,Bissell DM,Burkly LC
14-9018 was used in Immunohistochemistry to show that TNF-like weak inducer of apoptosis stimulates oval cell proliferation in the mouse liver through its receptor Fn14.
Thu Sep 01 00:00:00 UTC 2005
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Potrovita I,Zhang W,Burkly L,Hahm K,Lincecum J,Wang MZ,Maurer MH,Rossner M,Schneider A,Schwaninger M
14-9018 was used in Functional assays to demonstate the role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and membrane receptor Fn14, in neuronal cell death and neurodegeneration in vivo.
Wed Sep 22 00:00:00 UTC 2004